Literature DB >> 22639107

Thymic neoplasms: a clinical update.

Mark Mikhail1, Yasmin Mekhail, Tarek Mekhail.   

Abstract

Thymoma is a unique neoplasm of the anterior mediastinum that is frequently associated with indolent growth and a variety of paraneoplastic syndromes. One third of cases are detected during the evaluation of myasthenia gravis. Classification systems of thymoma have limited ability in accurately predicting prognosis and course of disease. Thus, staging is the only way to predict clinical behavior. Encapsulated tumors that are surgically resected carry the best prognosis. Adjuvant radiotherapy is recommended for incompletely excised and most invasive thymomas. Chemotherapy in anthracycline-based chemotherapy remains the most effective chemotherapy for neoadjuvant, adjuvant or palliative treatment.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22639107     DOI： 10.1007/s11912-012-0246-8

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  100 in total

1.  CLINICAL DISORDERS ASSOCIATED WITH THYMIC TUMORS.

Authors:  M RUBIN; B STRAUS; L ALLEN
Journal:  Arch Intern Med       Date:  1964-09

2.  Thymoma: a clinicopathologic study.

Authors:  P E BERNATZ; E G HARRISON; O T CLAGETT
Journal:  J Thorac Cardiovasc Surg       Date:  1961-10       Impact factor: 5.209

Review 3.  Thymoma--report of 71 cases and a review.

Authors:  A G Verstandig; D M Epstein; W T Miller; J A Aronchik; W B Gefter; W T Miller
Journal:  Crit Rev Diagn Imaging       Date:  1992

4.  Adjuvant radiotherapy after complete resection of thymoma.

Authors:  M Haniuda; M Morimoto; H Nishimura; O Kobayashi; T Yamanda; F Iida
Journal:  Ann Thorac Surg       Date:  1992-08       Impact factor: 4.330

5.  Prognostic factors and long-term results after thymoma resection: a series of 307 patients.

Authors:  J F Regnard; P Magdeleinat; C Dromer; E Dulmet; V de Montpreville; J F Levi; P Levasseur
Journal:  J Thorac Cardiovasc Surg       Date:  1996-08       Impact factor: 5.209

6.  Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma.

Authors:  Girum L Lemma; Ju-Whei Lee; Seena C Aisner; Corey J Langer; William J Tester; David H Johnson; Patrick J Loehrer
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

7.  Measurement of gastrointestinal protein loss using ceruloplasmin labeled with copper.

Authors:  T A Waldmann; A G Morell; R D Wochner; W Strober; I Sternlieb
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

8.  Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection.

Authors:  W J Curran; M J Kornstein; J J Brooks; A T Turrisi
Journal:  J Clin Oncol       Date:  1988-11       Impact factor: 44.544

Review 9.  Thymoma: radiologic-pathologic correlation.

Authors:  M L Rosado-de-Christenson; J Galobardes; C A Moran
Journal:  Radiographics       Date:  1992-01       Impact factor: 5.333

10.  Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation.

Authors:  Sunil Singhal; Joseph B Shrager; David I Rosenthal; Virginia A LiVolsi; Larry R Kaiser
Journal:  Ann Thorac Surg       Date:  2003-11       Impact factor: 4.330
View more
  7 in total

1.  Development of combined thymic carcinoma and thymoma in an extrathymic lesion during long follow-up for recurrent thymoma.

Authors:  Yasuhiro Ohue; Shunichiro Matsuoka; Hirotaka Kumeda; Hiroyuki Agatsuma; Akira Hyougotani; Masayuki Toishi; Takayuki Shiina; Kazuo Yoshida; Kunihiko Shingu; Toshirou Fukushima; Tomonobu Koizumi
Journal:  Mol Clin Oncol       Date:  2015-12-11

2.  Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma.

Authors:  Yukari Miki; Kana Hamada; Tadashi Yoshino; Katsuya Miyatani; Kiyoshi Takahashi
Journal:  Virchows Arch       Date:  2014-05-07       Impact factor: 4.064

3.  Malignant thymoma with metastasis associated with paraneoplastic myasthenia gravis.

Authors:  Hourossadat Hashemi Jazi; David M Harmon; Tuan Tran; Claude Denham
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

4.  99mTc MIBI THYMIC SCINTIGRAPHY IN DIAGNOSIS AND THERAPEUTIC DECISION MAKING: WHAT IS BEHIND THE IMAGE?

Authors:  C Ştefănescu; L Ionescu; R Dănilă; D Butcovan; R Tibu; S Bilha; D Timofte; C Vulpoi
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

Review 5.  Myasthenia gravis associated with invasive malignant thymoma: two case reports and a review of the literature.

Authors:  Said R Beydoun; Hui Gong; Nazely Ashikian; Richard Alan Rison
Journal:  J Med Case Rep       Date:  2014-10-13

6.  Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.

Authors:  Judit C Sági; Bálint Egyed; Andrea Kelemen; Nóra Kutszegi; Márta Hegyi; András Gézsi; Martina Ayaka Herlitschke; Andrea Rzepiel; Lili E Fodor; Gábor Ottóffy; Gábor T Kovács; Dániel J Erdélyi; Csaba Szalai; Ágnes F Semsei
Journal:  BMC Cancer       Date:  2018-07-03       Impact factor: 4.430

7.  A case of co-existing paraganglioma and thymoma.

Authors:  G Bano; D Sennik; M Kenchaiah; Ye Kyaw; Katie Snape; V Tripathi; P Wilson; I Vlahos; I Hunt; S Hodgson
Journal:  Springerplus       Date:  2015-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.